Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02700438Phase 3Completed
Phase 3, randomised, open-label trial of nitroglycerin in anal fissure, sponsored by Hospital General Universitario de Elche. Primary endpoint: Number of participants who discontinued the assigned treatment at 8 weeks. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02700438.